Dan Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

đź’Ľ Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

đź”® Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

 

Publications

đź“ť Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

đź“ť The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

đź“ť A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

đź“ť Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

 

Bin Zheng | Biomedicine | Best Researcher Award

Posted on by Book of Award

Prof. Dr. Bin Zheng | Biomedicine | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🌱

Prof. Dr. Bin Zheng’s academic journey began with a solid foundation in medical engineering and translational medicine. He further honed his expertise as a postdoctoral fellow at the Caroline School of Medicine, Sweden, laying the groundwork for a prolific career. His early pursuits in biomaterials and nanotechnology provided a strong base for his subsequent innovations and contributions to biomedical sciences.

Professional Endeavors 🏢

As a professor at Tianjin University's Academy of Medical Engineering and Translational Medicine, Dr. Zheng has led numerous research projects, including 10 completed and 6 ongoing endeavors. With over 30 impactful SCI publications, his work has gained recognition on a global scale. His collaborations with leading companies have fostered breakthroughs in cellular manufacturing and delivery technologies, enhancing both academic and industrial applications.

Contributions and Research Focus 🔬

Dr. Zheng’s work spans a wide range of fields, including biomaterials, cancer research, cellular microbiology, immunity, and nanobiotechnology. He has developed innovative therapeutic agents, including a nebulizable anti-bacterial spray targeting exosomes and stem cell extracts. His patents—70 published and 14 in progress—reflect his commitment to bridging the gap between laboratory research and clinical application.

Accolades and Recognition 🏆

Dr. Zheng’s outstanding contributions have earned him numerous awards, such as the Excellent Doctoral Dissertation of Tianjin Municipality and the First Prize for Innovative Achievements from the China Industry-University-Research Cooperation Association. Under his mentorship, graduate students have garnered over 20 prestigious awards, solidifying his role as an influential academic leader.

Impact and Influence 🌍

His research has been clinically translated and widely reported by media outlets like Science and Technology Daily and Science Net. As an editorial board member of prestigious journals, Dr. Zheng also influences the direction of global biomedical research. His international collaborations and contributions to standards like the Belt and Road LSEA 0006-2022 standard underscore his global impact.

Legacy and Future Contributions 🌟

Prof. Dr. Bin Zheng’s legacy lies in his innovative methodologies and translational focus, which continue to inspire the next generation of researchers. With ongoing projects in cutting-edge fields like optogenetics and cellular precision manufacturing, his future contributions are set to redefine the boundaries of medical engineering and translational medicine.

 

Publications

đź“„ Microorganism microneedle micro-engine depth drug delivery
Author(s): Zheng, B., Li, Q., Fang, L., Cheng, S.-X., Zhang, X.
Journal: Nature Communications
Year: 2024

đź“„ Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Author(s): Sun, W., Yun, F., Guo, Q., Zheng, B., Ruan, X.
Journal: Acta Biomaterialia
Year: 2024

đź“„ Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
Author(s): Du, Y., Guo, H.L., Su, X., Wang, T., Zheng, B.
Journal: Journal of Colloid and Interface Science
Year: 2024

đź“„ A self-assembling bioactive oligopeptide hydrogel for the treatment of edema following prepuce surgery
Author(s): Liu, J., Pei, Y., Huang, Y., Chen, L., Zhou, Y.
Journal: Journal of Materials Chemistry B
Year: 2024

đź“„ NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain
Author(s): Han, H., Li, B., Yang, R., Bai, Y., Yu, Y.
Journal: ACS Biomaterials Science and Engineering
Year: 2024

 

Jillian Perry | Materials Science | Best Researcher Award

Posted on by Book of Award

Assist Prof Dr. Jillian Perry | Materials Science | Best Researcher Award

University of North Carolina - Chapel Hill | United States

Author Profile

Google Scholar

🧠 Early Academic Pursuits

Assist. Prof. Dr. Jillian Perry's academic journey began with a Bachelor of Science in Chemical Engineering, awarded Cum Laude from the University of Florida in 2004, with a minor in Chemistry. Building on her solid foundation, she pursued a PhD in Biomedical Engineering at the same university, where she conducted pioneering research on chitosan nanotube synthesis for drug delivery applications. Her dissertation, supervised by Dr. John D. Steward and Dr. Charles R. Martin, laid the groundwork for a career focused on innovative solutions in drug delivery and nanotechnology.

đź’Ľ Professional Endeavors

Currently an Assistant Professor at the University of North Carolina’s Eshelman School of Pharmacy, Dr. Perry also contributes to the Center for Nanotechnology in Drug Delivery. Since joining UNC in 2010 as a Postdoctoral Research Associate at the Lineberger Comprehensive Cancer Center, she has been mentored by renowned researchers like Dr. Joseph M. DeSimone. Over the years, she progressed from a Research Associate Scientist to her current position, collaborating on high-impact research in pharmacoengineering and molecular pharmaceutics.

🧬 Contributions and Research Focus

Dr. Perry’s research explores 3D-printed microneedles, transdermal drug delivery systems, and nanoparticle-based cancer immunotherapies. She has authored numerous impactful publications, contributing extensively to fields such as tumor targeting and transdermal vaccination techniques. Her work includes significant studies on hydrogel-based cancer treatments and PRINT nanoparticle technology for enhanced therapeutic delivery.

🏆 Accolades and Recognition

Dr. Perry has been honored with several awards, such as the 2020 Junior Faculty Development Award and the NanoDDS Poster Award in 2018. Her 3D-printed vaccine patch technology received global attention and won the Fast Company’s World Changing Ideas Award in 2022. She was also recognized for her academic excellence with prestigious scholarships like the University Scholars Scholarship and Bright Futures Scholarship during her undergraduate years.

🌍 Impact and Influence

With an H-index of 19 and over 2,130 citations, Dr. Perry’s research has influenced the scientific community's understanding of nanomedicine and drug delivery technologies. Her innovative approaches in microneedle design and 3D printing for vaccine delivery have potential applications beyond academia, transforming practical healthcare delivery methods and advancing public health initiatives worldwide.

đź“ś Legacy and Future Contributions

As a thought leader in nanotechnology and biopharmaceuticals, Dr. Perry is expected to continue making groundbreaking contributions to transdermal vaccine development and targeted cancer therapies. Her active role in patenting novel drug delivery systems and designing biocompatible materials solidifies her legacy as a researcher committed to pioneering health solutions. Future contributions will likely include further advancements in non-invasive drug delivery and enhanced treatment efficacy in challenging medical fields, paving the way for transformative healthcare solutions.

 

Publications

📄  Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve dermal delivery of topically applied psoriasis treatments

Authors: PĂĽnnel LC, Palmtag M, Lunter DJ, Perry JL
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024

📄  3D-printed Lattice Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Authors: Rajesh NU, Hwang J, Xu Y, Saccone MA, Hung A, Hernandez RAS, Coates IA, Driskill MM, Dulay MT, Jacobson GB, Tian S, Perry JL#, DeSimone JM
Journal: Advanced Materials
 Year: 2024

📄  Development of a biocompatible 3D hydrogel scaffold using CLIP for the delivery of cell therapy to treat recurrent glioblastoma

Authors: Kass L, Morrent T, Zhang Y, DeVane C, Logan J, Tessema A, Perry JL#, Hingtgen SD
 Journal: Bioengineering and Translational Medicine
Year: 2024

📄  3D-Printed Microarray Patches for Transdermal Applications

Authors: Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyn D, Jacobson GB, Kwak JW, Lawrence M, Perry JL, Shea CO, Tian SM, DeSimone JM
 Journal: JACS Au
 Year: 2022

📄  Transdermal Vaccination via 3D Printed Microneedles Induces Potent Humoral and Cellular Immunity

Authors: Caudill CL, Perry JL, Illiadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM
Journal: PNAS
 Year: 2021

 

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

đź”® Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

 

Publications

đź“„ Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

đź“„ Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024

 

Govindaraj Sabarees | Materials Science | Best Researcher Award

Posted on by Book of Award

Dr. Govindaraj Sabarees | Materials Science | Best Researcher Award

Shri Venkateshwara College of Pharmacy | India

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Govindaraj Sabarees began his academic journey with a solid foundation in pharmacy. He earned his B. Pharmacy degree from Sankaralingam Bhuvaneshwari College of Pharmacy, Sivakasi, Tamil Nadu, achieving first-class honors. This was followed by an M. Pharmacy in Pharmaceutical Chemistry from C.L. Baid Metha College of Pharmacy, Chennai, where he also graduated with first-class distinction. His academic achievements laid the groundwork for his research-oriented career.

Professional Endeavors 🏢

Dr. Sabarees gained significant experience as a Bioanalytical Research Associate at Amaris Clinical, a division of Caplin Point Laboratories, Chennai. During this period, he honed his skills in bioanalytical methods, high-end equipment handling, and synthetic organic chemistry. His hands-on experience in these areas has contributed to his expertise in pharmaceutical research, particularly in the development and validation of analytical methods.

Contributions and Research Focus 🔬

Dr. Sabarees has made substantial contributions to pharmaceutical research, particularly in the field of wound healing and molecular docking. His research includes the discovery of curcumin analogs as potential wound healing agents and the development of novel electrospun nanofibers for biomedical applications. His work has been widely published in reputable journals, showcasing his ability to bridge the gap between theoretical research and practical applications in medicine.

Accolades and Recognition 🏆

Throughout his career, Dr. Sabarees has received recognition for his contributions to pharmaceutical research. His participation in various national and international conferences, where he has presented his findings, has earned him a respected place in the academic and research community. His publications in high-impact journals further underscore his commitment to advancing the field of pharmaceutical sciences.

Impact and Influence 🌍

Dr. Sabarees's research has had a significant impact on the development of new therapeutic agents and materials, particularly in the area of wound management. His work on molecular docking and dynamics simulations has opened new avenues for drug discovery and development. His influence extends to his role as a mentor and educator, where he has guided junior researchers and pharmacy students, helping shape the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

As Dr. Sabarees continues to advance in his career, his ongoing research and future projects promise to make lasting contributions to the field of pharmaceutical sciences. His work on electrospun nanofibers and molecular docking is likely to lead to new breakthroughs in drug delivery systems and therapeutic materials. Dr. Sabarees's legacy will be one of innovation, dedication, and a commitment to improving healthcare outcomes through cutting-edge research.

 

Publications

  • đź“– Fabrication of Quercetin-Functionalized Morpholine and Pyridine Motifs-Laden Silk Fibroin Nanofibers for Effective Wound Healing in Preclinical Study
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Siddan Gouthaman, Viswas Raja Solomon, Subramani Kandhasamy
    Journal: Pharmaceutics
    Year: 2024
  • đź“– Advances in Electrospun Chitosan Nanofiber Biomaterials for Biomedical Applications
    Authors: Ganesan Padmini Tamilarasi, Manikandan Krishnan, Govindaraj Sabarees, S. Gouthaman, Alagarsamy Veerchamy, Viswas Raja Solomon
    Journal: Materials Advances
    Year: 2023
  • đź“– Discovery of new naphthyridine hybrids against enoyl-ACP reductase (inhA) protein target of Mycobacterium tuberculosis: Molecular docking, molecular dynamics simulations studies
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Viswas Raja Solomon
    Journal: Chemical Physics Impact
    Year: 2023
  • đź“– Recent Trends in Electrospun Antibacterial Nanofibers for Chronic Wound Management
    Authors: Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Krishnan Manikandan, Siddan Gouthaman, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Current Nanomedicine
    Year: 2023
  • đź“–Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing
    Authors: Govindaraj Ajith, Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Siddan Gouthaman, Krishnan Manikandan, Vadivel Velmurugan, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Drugs and Drug Candidates
    Year: 2023

 

Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Regenerative Research Sciences Private Limited | India

Author profile

Scopus

Early Academic Pursuits

Dr. Vijayalakshmi Venkatesan began her academic journey with a B.Sc. in Botany, Zoology, and Chemistry, achieving First Class with Distinction. She pursued her passion further with an M.Sc. in Biochemistry, securing the second rank in the university. Her academic pursuit culminated in a Ph.D. in Biochemistry from the National Institute of Nutrition/Osmania University. Following this, she engaged in postdoctoral research at the Centre for Cellular and Molecular Biology.

Professional Endeavors

Dr. Vijayalakshmi Venkatesan's professional journey has been marked by significant roles in academia and research. She served as the Director-Grade Scientist and Head of Cell & Molecular Biology and Stem Cell Research at the National Institute of Nutrition, ICMR, Hyderabad. Currently, she holds the position of Director-Research at Movva Health Care LLP, RegenOrthoSport, where she continues to contribute to cutting-edge research in biochemistry and stem cell research.

Contributions and Research Focus

Her research focuses on regenerative medicine, particularly in addressing non-communicable diseases (NCDs) like diabetes, obesity, and knee osteoarthritis. Dr. Vijayalakshmi Venkatesan's work involves understanding the pathophysiology of these diseases at the cellular and molecular levels. She has made significant strides in the isolation, characterization, and therapeutic application of mesenchymal stem cells (MSCs) derived from various sources, including placenta and bone marrow. Additionally, her research explores the potential of nutraceuticals in managing these conditions, highlighting the beneficial effects of compounds like stigmasterol, gingerol, and shogaol.

Accolades and Recognition

Dr. Vijayalakshmi Venkatesan's contributions to the field have been recognized through numerous awards and honors. She has been felicitated with awards such as the Woman of Excellence Award, Venus International Award for Excellence in Biochemistry and Stem Cell Research, and the Dr. S.N. Acharya Felicitation Award. Her expertise has also earned her fellowship status in prestigious organizations like the National Academy of Medical Sciences and the Telangana Academy of Sciences.

Impact and Influence

Dr. Vijayalakshmi Venkatesan's research has left a significant impact on both academia and clinical practice. Her findings have been published extensively in peer-reviewed journals, with over 100 scientific articles and several book chapters to her credit. She has also been granted multiple patents for her innovative research in liver cell therapy and mesenchymal stem cell transplantation. Moreover, she actively participates in various professional societies and serves on the editorial boards of esteemed journals in the field.

Legacy and Future Contributions

Dr. Vijayalakshmi Venkatesan's legacy lies in her pioneering work at the intersection of biochemistry, genetics, and regenerative medicine. Her ongoing efforts in translational research aim to bridge the gap between laboratory discoveries and clinical applications, with a focus on improving healthcare outcomes for patients with metabolic disorders and musculoskeletal conditions. As she continues to lead research initiatives and mentor future scientists, her contributions are poised to shape the future of regenerative medicine and personalized healthcare.

Notable Publications

Alleviation of diabetes mellitus through the restoration of β-cell function and lipid metabolism by Aloe vera (L.) Burm. f. extract in obesogenic WNIN/GR-Ob rats  2021 (19)

Elevated ATP, cytokines and potential microglial inflammation distinguish exfoliation glaucoma from exfoliation syndrome 2022 (7)

The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study 2017 (10)